Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial

Günal A. İ., Özalp G., Yoldaş T., GÜNAL S., Kırcıman E., Çeliker H.

NEPHROLOGY DIALYSIS TRANSPLANTATION, vol.19, no.12, pp.3137-3139, 2004 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 12
  • Publication Date: 2004
  • Doi Number: 10.1093/ndt/gfh496
  • Journal Name: NEPHROLOGY DIALYSIS TRANSPLANTATION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.3137-3139
  • Erciyes University Affiliated: No

Abstract

Background. Uraemic pruritus is a common and distressing symptom in patients on haemodialysis for chronic renal failure. Gabapentin is an anticonvulsant that alleviates neuropathic pain. We conducted a double-blind. placebo-controlled, crossover study to assess its effectiveness against renal itch.